.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Leukopenia remains a significant clinical challenge for many patients, often resulting from chemotherapy or immune system disorders. Recent research highlights the potential of caffeic acid for leukopenia as an effective therapeutic adjunct. This natural phenolic compound, found in coffee and various plant-based sources, shows significant promise in improving white blood cell (WBC) counts. A new systematic review now provides high-level evidence supporting its clinical application.
A meta-analysis of thirty-three randomized controlled trials involving 2,483 patients evaluated the impact of caffeic acid tablets. The findings demonstrated a substantial increase in WBC counts among treated individuals. Specifically, the clinical effectiveness was significantly higher in the caffeic acid group compared to the control group. Furthermore, the standardized mean difference (SMD) in WBC count improvement was 1.83, indicating a very strong positive effect.
Moreover, the researchers noted that caffeic acid tablets also benefit patients with thrombocytopenia. Although the study primarily focused on white blood cells, the broad hematological support is highly encouraging. Consequently, this supplement could serve as a valuable tool in oncology and hematology wards across India. Clinicians may find it useful for managing patients who experience bone marrow suppression.
Safety remains a top priority for any clinical intervention. This systematic review confirmed that caffeic acid tablets did not lead to serious adverse events. Most reported side effects were mild and resolved quickly without intervention. Additionally, the mechanism of action involves protecting hematopoietic cells from oxidative stress and inflammation. Therefore, practitioners can consider this option with confidence for long-term management.
Caffeic acid promotes the recovery of white blood cell counts by stimulating hematopoiesis and protecting bone marrow cells from oxidative damage. It is particularly effective as an adjunct therapy for chemotherapy-induced leukopenia.
Current clinical evidence suggests that caffeic acid tablets are generally well-tolerated. Meta-analyses of multiple trials show no serious adverse events, although patients should always consult their physician before starting any new supplement.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Dai F et al. Caffeic acid for the management of leukopenia: a systematic review and meta-analysis. J Health Popul Nutr. 2026 Feb 14. doi: 10.1186/s41043-025-01197-3. PMID: 41691356.
Silva T, et al. Caffeic Acid Derivatives: A Review of Synthesis and Structure-Activity Relationship as Potential Antitumor Agents. Molecules. 2021.
Miao D, et al. Caffeic acid protects against radiation-induced hematopoietic injury. Scientific Reports. 2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A meta-analysis of 33 trials confirms that caffeic acid tablets significantly improve white blood cell counts and clinical effectiveness in leukopenia patie...
6 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
